ACC主席Ralph G.Brindis 美国旧金山加利福尼亚大学

　　International Circulation: On a macro level， what is the interest of the ACC in China and particularly what is your interest in coming to China?
　　《国际循环》：在宏观层面上，ACC在中国的兴趣是什么？特别是您来中国的兴趣所在是什么？
　　Prof Brindis: It has been a really exciting time for me to be in China over the last couple of years. China has some very dynamic leaders such as Professor Hu， who have great visions for the country. It has been a particular honor in collaborating with him and his fellow colleagues in trying to， not only improve international health， but the health of the Chinese people. The American College of Cardiology feels it is one of its missions to help facilitate true leaders such as Dayi and his colleagues to do such. There are a lot of challenges here in China related to non-communicable diseases particularly cardiovascular disease and particularly related to tobacco use and other primary risk factors for coronary disease and trying to help offer some of the strategies that we found helpful in the United States that your leaders in cardiology can apply here in China. It is a particular thrill for me personally.
　　Brindis教授：在过去几年里，到中国对我来说一直是令人非常激动的时刻。中国有一些非常有活力的领导者如胡教授，他对这个国家有着伟大的愿景。我非常荣幸在努力提高不仅是国际健康还有中国人民的健康上与他和他的同事们合作。美国心脏病学学会认为帮助促进真正的领导者如大一及其同事这样做是其使命之一。在中国有许多与非传染性疾病尤其是心血管疾病相关的挑战，尤其是与吸烟以及其他冠状动脉疾病的主要危险因素相关的挑战，设法帮助提供一些我们在美国发现有帮助且你们的心脏病学领袖在中国可以应用的策略。这对我个人来说是特别令人兴奋的经历。
　　International Circulation: Is there anything that hasn’t been achieved in the Unites States that you feel there is an opportunity to do here in China?
　　Prof Brindis: Of course things in the United States are far from perfect. We have so many opportunities to improve the care of our own patients and our society. But there are a number of things that we have learned in terms of: translating evidence-based medicine into the bedside and the patient; to the delivery of systems of care whether it be for acute myocardial infarction or whether it be for secondary or primary prevention; and in the development of registries. In this case， the American College of Cardiology has a very robust registry system for both hospital-based care and ambulatory care. Some of the visionary leaders here in China appreciate some of the things we have created and the opportunities that applying them here in China can offer the population.  It gives me a personal thrill with my own background in public health and my own desire to conquer cardiovascular disease internationally， to be able to be a part of that process of improved care in a small way.
　　《国际循环》：是否有什么事情在美国尚未实现而您觉得在中国有机会取得呢？
　　Brindis教授：当然，在美国事情还远不完美。我们有很多机会来改善我们自己患者和我们社会的医疗。但我们已经学到了很多事情，包括如下方面：将循证医学转化入临床和患者中；医疗系统的实施，无论是对急性心肌梗死或无论是对二级或一级预防；以及在注册中心的发展上。既然这样，对医院为基础的医疗以及门诊医疗，美国心脏病学学会有一个非常强大的注册系统。在中国，一些富有远见的领导者重视我们已经创造的一些东西以及在中国提供给他们的机会，可以提供给人群。鉴于我自己在公共卫生上的背景，攻克国际上的心血管疾病以及在某种程度上能够成为改善医疗进程的一部分令我很是兴奋，而且这是我自己的心愿。